OR WAIT null SECS
August 02, 2023
Only a significant joint effort across the supply chain will help to make healthcare more sustainable and reduce the impact of climate change on global health.
mRNA may be a modality whose chief advances are yet to come.
July 02, 2023
The UK and EU have negotiated a new draft deal for Britain to re-join the Horizon Europe research programme.
If we view a change opposite of one’s interest as antithetical to innovation, we risk losing sight of our ultimate goal.
June 02, 2023
Despite being a relatively small nation, Switzerland is booming for biotech innovation.
Vaccine nationalism strengthens viruses and poses deadly risks for all involved.
May 02, 2023
INTERPHEX was back in full swing with Keynote sessions highlighting cutting-edge technologies that are setting the stage for the bio/pharma industry’s future.
Strike action is impacting numerous sectors across Europe, including the bio/pharma industry.
April 02, 2023
What can we take away from Pfifzer's acquisition of Seagen?
A further setback to the publication of the pharmaceutical legislative changes in Europe may mean time is running out for appropriate review before 2024 parliamentary elections.